FIR filed against Mylan Labs for alleged Rs 6 crore fraud
Advertisement
Brewing controversy, the Mumbai Police's Economic Offences Wing (EOW) has filed an FIR against drug major Mylan Laboratories for alleged irregularities in the procurement of Remdesivir injections during Covid-19 pandemic at inflated prices of Rs 1,568 per vial despite a contract of Rs 665 per vial, resulting in a staggering loss of Rs 5.96 crore to the government.
Besides Mylan, officials from the central purchasing department of the Brihanmumbai Municipal Corporation (BMC) and the supplier of the injections are also in soup as they are now facing charges of alleged fraud.
For more details, check out the link given below:
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.